Pharmacokinetics of Rivaroxaban After Bariatric Surgery
NCT04180436
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
OTHER
Sponsor class
Conditions
Bariatric Surgery
Morbid Obesity
Interventions
DRUG:
rivaroxaban 20 mg once daily 8 days
Sponsor
University Hospital, Brest
Collaborators
[object Object]